Hepatitis Diagnostic Tests Market 2028 By Product Type, Test Type End User and Geography | The Insight Partners

report image

Hepatitis Diagnostic Tests Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Instruments, Kits and reagents, Point of care tests); Test Type (Blood tests, Imaging tests, Liver biopsy) End User (Hospitals, Diagnostic Laboratories, Blood Banks, Others) and Geography

Report Code: TIPRE00003792 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


The hepatitis diagnostic tests is a set of blood tests that can be used to detect current or previous hepatitis A, B, or C infection. It can test blood samples for multiple types of hepatitis viruses at once. Each of the hepatitis viruses can be detected using antibody and antigen assays.


The "Hepatitis Diagnostic Tests Market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hepatitis Diagnostic Tests Market with detailed market segmentation by of Product type, Test type, End Users. The Hepatitis Diagnostic Tests Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Hepatitis Diagnostic Tests Market and offers key trends and opportunities in the market.


  •  n the basis of product type, the market is segmented into Instruments, Kits and reagents, Point of care tests.
  •  n the basis of test type, the market is segmented into Blood tests, Imaging tests, Liver biopsy.
  •  n the basis of end User, the market is segmented into Hospitals, Diagnostic Laboratories, Blood bank, others.



  •  The market for hepatitis diagnostic tests is expected to develop in the next years, owing to factors such as the rising prevalence of hepatitis, increased awareness of the benefits of early diagnostics, and an increase in the number of blood transfusions and donations.
  •  Furthermore, different technology advances and the development of affordable and high-quality hepatitis diagnostic tests by rising Asian and Latin American enterprises are expected to provide considerable growth prospects in the next years.


    High costs associated with testing, particularly Nucleic Acid Amplification Testing (NAAT), are projected to hinder market expansion to some extent. Furthermore, limited availability to low-cost and reliable diagnostic tests, particularly in developing countries, as well as the lack of a mandate for NAAT, are projected to limit worldwide market growth to some extent during the forecast period.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hepatitis Diagnostic Tests Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hepatitis Diagnostic Tests Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Hepatitis Diagnostic Tests Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Hepatitis Diagnostic Tests Market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the Hepatitis Diagnostic Tests Market in 2020.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the Hepatitis Diagnostic Tests Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Hepatitis Diagnostic Tests Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Hepatitis Diagnostic Tests Market in the global market. Below mentioned is the list of few companies engaged in the Hepatitis Diagnostic Tests Market.

The report also includes the profiles of key players in Hepatitis Diagnostic Tests Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Abbott
  •  F. Hoffmann La-Roche Ltd.
  •  Bio-Rad Laboratories, Inc.
  •  Siemens AG
  •  Danaher
  •  DiaSorin S.p.A.
  •  Grifols, S.A.
  •  Hologic Inc
  •  MedMira Inc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies

1. Abbott
2. F. Hoffmann La-Roche Ltd.
3. Bio-Rad Laboratories, Inc.
4. Siemens AG
5. Danaher
6. DiaSorin S.p.A.
8. Grifols, S.A.
9. Hologic Inc
10. MedMira Inc
11. Danaher Corporation
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount